| 摘要 |
Use of an iontophoretic transdermal patch in the manufacture of a medical device for delivering a triptan compound or a salt thereof to a subject in need thereof, wherein the delivering comprises the steps of: (a) providing an iontophoretic transdermal patch containing an amount of the triptan compound or a salt thereof; and (b) using an uninterrupted two-stage patterned delivery sequence which includes initial first stage delivery at a relatively high rate followed by a second stage delivery at a lower rate to provide a waveform delivery pattern in which a therapeutically effective dosage level is reached in a subject in generally less than one hour and a maintenance level is continued for one or more hours. |
